Impact of China Guidelines for Pharmacoeconomic Evaluations on study quality: a systematic review of economic evaluations in China
Abstract Objective Given the critical role of pharmacoeconomics in supporting decision-making and the urgent need to address the study quality of economic evaluations (EEs), this study aimed to analyse whether the China Guidelines for Pharmacoeconomic Evaluations (China PE Guidelines, 4 versions) im...
Saved in:
| Main Authors: | Shihuan Cao, Wanxian Liang, Changhao Liang, Huansen Lin, Chenxi Gao, Lujia Yang, Yuming Liu, Yusi Suo, Kexin Liu, Yunzheng Chen, Lining Zhang, Hanfei Wang, Han Wang, Xuejing Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Health Economics Review |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13561-025-00650-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer
by: N. A. Avxentyev, et al.
Published: (2020-02-01) -
Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2016-06-01) -
Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
by: V. V. Ivanov, et al.
Published: (2015-04-01) -
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019-01-01) -
PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
by: M. Yu. Frolov, et al.
Published: (2017-08-01)